Enlarged, pigmented portal lymph nodes are often seen in end-stage primary biliary cirrhosis. The pigment, initially thought to be bile,' has recently been shown to have the staining characteristics oflipofuscin in two cases reported by Benbow Although portal lymphadenopathy associated with lipofuscin is a common finding in primary biliary cirrhosis, it is clearly not confined to this condition. We have found a similar pattern of lymph node enlargement in other chronic liver diseases-notably, those with a prominent cholestatic componentprimary sclerosing cholangitis, chronic liver allograft rejection, and extrahepatic biliary atresia. By contrast, in cases of non-cholestatic chronic liver disease, portal lymph nodes were less commonly enlarged and contained little or no lipofuscin pigment. The one exception in which large amounts of pigment were present was a case of "cryptogenic" cirrhosis occurring in a 20 year old woman. Although there were no specific clues to aetiology, the histological pattern was suggestive of chronic biliary disease with large amounts of bile pigment and moderate amounts of copper-associated protein present.
A previous study by Roggendorf described lipofuscin granules in portal lymph nodes in a variety of conditions including alcoholic cirrhosis, sarcoidosis, pancreatic carcinoma and cholelithiasis.8 The latter three conditions may all have a cholestatic course.
Lymph node enlargement associated with lipofuscin can also be seen in more distant sites of lymphatic drainage from the liver. Hamazaki described lipofuscin granules in mesenteric lymph nodes from a case of pericholangitis,9 and we have seen extensive intra-abdominal lymph node enlargement, associated with pigment deposits in one case of primary biliary cirrhosis and another of extrahepatic biliary atresia at necropsy (unpublished observation).
The duration of disease also seems to be an important factor in determining the amount of pigment present. The largest amounts were seen in cases of primary biliary cirrhosis and primary sclerosing cholangitis which generally have a duration of several years before end-stage disease requiring transplantation is reached. Smaller amounts of pigment were present in cases of extrahepatic biliary atresia and chronic liver allograft rejection in which the median duration ofillness in this study had been 11 and three months, respectively. Other processes, including rejection and replacement of donor lymphoid cells with those from the host, may help cause enlargement of donor lymph nodes attached to the grafted liver."'01 As far as we are aware, however, accumulation of lipofuscin has not been previously described in nodes attached to the liver allograft. No portal lymph nodes were detected in cases of acute liver disease including failed non-rejection liver grafts in which the median survival had been 13 days. Severe cholestasis is a common histological finding in many of these conditions4"6 -13 and the absence of any portal lymph nodes in these cases further supports the suggestion that prolonged cholestasis is required to produce the characteristic lymphadenopathy associated with lipofuscin.
Our study also showed another, apparently distinct, population of ceroid laden macrophages in paracortical and mantle zones of portal lymph nodes. 1164 Although these were clearly distinguishable from sinus histiocytes laden with lipofuscin by histological examination and long ZN staining, there was some overlap in the staining reactions with PAS-diastase. This is perhaps not surprising as lipofuscin and ceroid are closely related chemically and the two terms are often used interchangeably. Pearse proposes a unifying concept of lipofuscins in which ceroid is regarded as a typical lipofuscin in the early stages ofoxidation. '4 In the context of liver disease ceroid and lipofuscin are generally regarded as distinct entities. Ceroid refers to brown pigment in phagocytes which is PAS-diastase positive but not necessarily acid fast; lipofuscin, on the other hand, represents granular material in hepatocytes that is acid fast and displays a variable degree of PAS positivity. '5 16 The material seen in sinus histiocytes in our cases thus has staining properties corresponding to lipofuscin.
The clinical importance of these two apparently distinct populations of histiocytes containing different types of "lipofuscins" is uncertain. Although they often occurred in the same nodes, it was impossible to establish a definite relation between the presence or amounts of the two pigments present. Overall, ceroid pigment was present in much smaller quantities than lipofuscin and did not seem to be an important factor in producing lymph node enlargement.
Portal lymph node enlargement was a common finding in livers with primary tumours. The histiological appearances, however, were different from those seen in chronic cholestatic liver disease. Nodes draining neoplastic livers showed a mixed picture of simple sinus histiocytosis and follicular hyperplasia and most cases contained no lipofuscin deposits. The appearances were similar to those described in nodes draining other tumour sites, such as the breast and stomach. '7 20 How can the apparent relation between chronic cholestatic liver disease and the accumulation of lipofuscin pigment in portal lymph nodes be explained? The relation is unlikely to be a simple chemical one. Bile is a substance with a complex chemical composition which includes a mixture of water, electrolytes, bile salts, bilirubin, phospholipids, cholesterol and several enzymes.2' Lipofuscin also has a complex composition and the term is used to describe a group of substances which are heterogeneous in their chemical properties. ' 4 Chemical analysis is difficult due to pronounced insolubility,22 but the pigments seem to be composed of lipids and phospholipids complexed with protein23 and are thought to be derived from lipid precursors by an oxidative process involving free radicals.24 A possible mechanism might be the transport of bile from liver to regional lymph nodes in the early stages of cholestasis and the subsequent oxidation of lipid constituents of Huibscher, Harrison bile to produce lipofuscin. The absence of bile pigments in any of the lymph nodes we studied, however (including may nodes attached to livers with considerable intracellular bile) fails to support this hypothesis.
The presence of enzymes such as non-specific esterase,25 acid phosphatase'4 and a variety of other acid hydrolases26 in lipofuscin granules suggests that these granules are lysosomal in origin. Why these should selectively accumulate in chronic cholestatic liver disease is uncertain, but it is interesting to speculate on the possible role ofcopper accumulation. Granules containing copper-associated protein (CAP) are an extremely common finding in periportal hepatocytes in chronic cholestatic liver disease, particularly cases of primary biliary cirrhosis and primary sclerosing cholangitis.27-30 The granules containing CAP also contain lysosomal enzymes3'"-and stain positively with a variety of stains for lipofusin.4 These granules may therefore be a source of lipofuscin that is released from damaged hepatocytes and carried to portal lymph nodes to produce the characteristic lymphadenopathy seen in association with chronic cholestasis. The finding of black, orcein positive granules in 30% of the nodes with lipofuscin deposits in sinus histiocytes further supports this hypothesis and suggests that CAP may also be carried to portal lymph nodes in long standing cholestasis. The orcein positive granules had a different distribution from lipofuscin, however, being mainly present in paracortical/mantle zone histiocytes in association with ceroid pigment.
The functional importance of lipofuscin induced portal lymphadenopathy is uncertain. Most cases are asymptomatic with enlarged nodes only detected at laparotomy or necropsy. Occasional cases of lymph node enlargement sufficiently gross to cause bile duct compression have been described.35 They may convey a false impression of neoplastic disease, a problem likely to be encountered by the radiologist with the use of increasingly sensitive imaging techniques as well as the surgeon.
From a diagnostic viewpoint, our study suggests that the finding of large amounts of lipofuscin in enlarged portal lymph nodes is a good indicator of underlying chronic cholestatic liver disease.
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